Financhill
Buy
58

WMT Quote, Financials, Valuation and Earnings

Last price:
$113.0700
Seasonality move :
5.43%
Day range:
$112.1000 - $114.7300
52-week range:
$79.8100 - $117.4500
Dividend yield:
0.83%
P/E ratio:
39.54x
P/S ratio:
1.29x
P/B ratio:
9.35x
Volume:
23.3M
Avg. volume:
20.3M
1-year change:
24.13%
Market cap:
$898.4B
Revenue:
$681B
EPS (TTM):
$2.85

Analysts' Opinion

  • Consensus Rating
    Walmart, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 31 Buy ratings, 1 Hold rating, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $121.5641, Walmart, Inc. has an estimated upside of 7.85% from its current price of $112.7200.
  • Price Target Downside
    According to analysts, the lowest downside price target is $62.0000 representing 45% downside risk from its current price of $112.7200.

Fair Value

  • According to the consensus of 33 analysts, Walmart, Inc. has 7.85% upside to fair value with a price target of $121.5641 per share.

WMT vs. S&P 500

  • Over the past 5 trading days, Walmart, Inc. has underperformed the S&P 500 by -0.19% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Walmart, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Walmart, Inc. has grown year-over-year revenues for 39 quarters straight. In the most recent quarter Walmart, Inc. reported revenues of $179.5B.

Earnings Growth

  • Walmart, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Walmart, Inc. reported earnings per share of $0.77.
Enterprise value:
962.7B
EV / Invested capital:
5.63x
Price / LTM sales:
1.29x
EV / EBIT:
33.22x
EV / Revenue:
1.37x
PEG ratio (5yr expected):
2.31x
EV / Free cash flow:
63.07x
Price / Operating cash flow:
59.37x
Enterprise value / EBITDA:
22.49x
Gross Profit (TTM):
$168B
Return On Assets:
8.66%
Net Income Margin (TTM):
3.32%
Return On Equity:
24.17%
Return On Invested Capital:
14.48%
Operating Margin:
3.73%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Income Statement
Revenue $638.8B $673.8B $703.1B $169.6B $179.5B
Gross Profit $155B $166.4B $168B $42.2B $41.2B
Operating Income $25.3B $28.7B $29B $6.7B $6.7B
EBITDA $36.9B $41.5B $42.8B $10B $10.3B
Diluted EPS $2.01 $2.44 $2.85 $0.57 $0.77
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Balance Sheet
Current Assets $83B $87.7B $88.4B $86.9B $92.9B
Total Assets $244.9B $247.7B $259.2B $263.4B $288.7B
Current Liabilities $87.6B $101.4B $104.2B $102.6B $115.7B
Total Liabilities $154.1B $167.3B $173.4B $168.9B $186.1B
Total Equity $90.8B $80.4B $85.8B $94.5B $102.5B
Total Debt $55.7B $57.1B $58.3B $56.7B $58.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Cash Flow Statement
Cash Flow Operations $32.2B $39.6B $41B $6.6B $9.1B
Cash From Investing -$24.4B -$18.6B -$27.7B -$2.5B -$7.8B
Cash From Financing -$7.3B -$22.9B -$12.2B -$2.7B -$19M
Free Cash Flow $12.7B $17B $15.3B $372M $1.9B
WMT
Sector
Market Cap
$898.4B
$123.2M
Price % of 52-Week High
95.97%
71.52%
Dividend Yield
0.83%
0%
Shareholder Yield
1.77%
2.3%
1-Year Price Total Return
24.13%
-6.25%
Beta (5-Year)
0.660
0.255
Dividend yield:
0.83%
Annualized payout:
$0.83
Payout ratio:
30.65%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $112.5163
200-day SMA
Buy
Level $100.5929
Bollinger Bands (100)
Buy
Level 99.985 - 111.065
Chaikin Money Flow
Buy
Level 2.1B
20-day SMA
Sell
Level $113.6380
Relative Strength Index (RSI14)
Buy
Level 52.6601
ADX Line
Buy
Level 16.0799
Williams %R
Neutral
Level -63.4064
50-day SMA
Buy
Level $108.8020
MACD (12, 26)
Buy
Level 0.7811
25-day Aroon Oscillator
Sell
Level -28
On Balance Volume
Neutral
Level 6.7B

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.3281)
Buy
CA Score (Annual)
Level (0.3629)
Buy
Beneish M-Score (Annual)
Level (-2.6807)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.3868)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Stock Forecast FAQ

In the current month, WMT has received 31 Buy ratings 1 Hold ratings, and 1 Sell ratings. The WMT average analyst price target in the past 3 months is $121.5641.

  • Where Will Walmart, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Walmart, Inc. share price will rise to $121.5641 per share over the next 12 months.

  • What Do Analysts Say About Walmart, Inc.?

    Analysts are divided on their view about Walmart, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Walmart, Inc. is a Sell and believe this share price will drop from its current level to $62.0000.

  • What Is Walmart, Inc.'s Price Target?

    The price target for Walmart, Inc. over the next 1-year time period is forecast to be $121.5641 according to 33 Wall Street analysts, 31 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is WMT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Walmart, Inc. is a Buy. 31 of 33 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of WMT?

    You can purchase shares of Walmart, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Walmart, Inc. shares.

  • What Is The Walmart, Inc. Share Price Today?

    Walmart, Inc. was last trading at $113.0700 per share. This represents the most recent stock quote for Walmart, Inc.. Yesterday, Walmart, Inc. closed at $112.7200 per share.

  • How To Buy Walmart, Inc. Stock Online?

    In order to purchase Walmart, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock